VBS.AX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 03:31):

Stats
Dzisiejszy wolumen	5 360.00
Średni wolumen	7 814.00
Kapitalizacja rynkowa	12.50M
EPS	$0 ( 2024-02-21 )
Następna data zysków	( $0 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.87
ATR14	$0 (0.00%)

Vectus Biosystems Limited Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vectus Biosystems Limited Finanse

Annual	2023
Przychody:	$1.35M
Zysk brutto:	$1.31M (96.51 %)
EPS:	$-0.0719

FY	2023
Przychody:	$1.35M
Zysk brutto:	$1.31M (96.51 %)
EPS:	$-0.0719

FY	2022
Przychody:	$1.30M
Zysk brutto:	$1.28M (98.45 %)
EPS:	$-0.120

FY	2021
Przychody:	$180.00
Zysk brutto:	$180.00 (100.00 %)
EPS:	$-0.183

Financial Reports:

No articles found.

Vectus Biosystems Limited

Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The company was incorporated in 2005 and is based in Rosebery, Australia.